UniProtKB/Swiss-Prot P40692 : Variant p.Asp485His
DNA mismatch repair protein Mlh1
Gene: MLH1
Feedback ?
Variant information
Variant position:
485
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:
US
The variants are classified into three categories: LP/P, LB/B and US.LP/P: likely pathogenic or pathogenic. LB/B: likely benign or benign. US: uncertain significance
Residue change:
From Aspartate (D) to Histidine (H) at position 485 (D485H, p.Asp485His).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:
Change from medium size and acidic (D) to medium size and polar (H)
The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:
-1
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another: Lowest score: -4 (low probability of substitution).Highest score: 11 (high probability of substitution). More information can be found on the following page
Variant description:
In LYNCH2; uncertain significance.
Any additional useful information about the variant.
Other resources:
Links to websites of interest for the variant.
Sequence information
Variant position:
485
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:
756
The length of the canonical sequence.
Location on the sequence:
TSSNPRKRHREDSDVEMVED
D SRKEMTAACTPRRRIINLTS
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:
The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human TSS--NPRKRHREDSDVEMVEDD SRK-EMTAACTPRR----RI-INLTS
Mouse TSSPGSSRKRHREDSDVEMVENA SGK-EMTAACYPRR----
Rat PSSPGSSRKRHPEDSDVEMMEND SRK-EMTAACYPRR----
Slime mold TTTTTTTTTTATTKSNSPASKND IKKLQEHTFITPRKTRKY
Baker's yeast YKVPSIADD---EKNALPISKDG YIR-------VPKE----
Fission yeast ANSNKNATNDIKDLQTEEIVEEG NS----------------
Sequence annotation in neighborhood:
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
2 – 756
DNA mismatch repair protein Mlh1
Region
400 – 491
Disordered
Region
410 – 650
Interaction with EXO1
Compositional bias
464 – 491
Basic and acidic residues
Modified residue
477 – 477
Phosphoserine
Mutagenesis
471 – 471
K -> N. Affects binding to importins alpha, including KPNA2, hence may affect import to the nucleus.
Mutagenesis
472 – 472
R -> N. Affects binding to importins alpha, including KPNA2, hence may affect import to the nucleus.
Literature citations
hMLH1 and hMSH2 mutations in families with familial clustering of gastric cancer and hereditary non-polyposis colorectal cancer.
Kim J.C.; Kim H.C.; Roh S.A.; Koo K.H.; Lee D.H.; Yu C.S.; Lee J.H.; Kim T.W.; Lee H.I.; Beck N.E.; Bodmer W.F.;
Cancer Detect. Prev. 25:503-510(2001)
Cited for: VARIANTS GASTRIC CANCER ARG-106; GLN-109 AND LYS-635; VARIANTS LYNCH2 GLY-234; ILE-321; HIS-485 AND ALA-631; VARIANT CRC ILE-472;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.